17 April 2018 : Clinical Research
Anti-Interferon Alpha Antibodies in Patients with High-Risk BCR/ABL-Negative Myeloproliferative Neoplasms Treated with Recombinant Human Interferon-α
DOI: 10.12659/MSM.907876
Med Sci Monit 2018; 24: CLR2302-2309
HTML version available soon